FDA Inspection
Exquisite CorporationExquisite Corporation – FDA Inspection, Aug 1, 2024
Record Details
This FDA Inspection record concerns Exquisite Corporation, with an inspection on August 1, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 95345e92-b26f-4201-a42b-a6dc10f58cab
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1245264
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.84(d)(2)Component identification test
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.105(b)Distinctive ID or code not recorded in batch record
- 21 CFR 211.166(a)(4)Testing in same container - closure system
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Exquisite Corporation
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 26, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 9, 2013 | NAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
Other documents for Exquisite Corporation
- FDA Inspection 1205627 - 2023-04-26
- FDA Inspection 815499 - 2013-01-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.